首页> 美国卫生研究院文献>Journal of Arrhythmia >Atrial fibrillation deteriorates tricuspid regurgitation following implantable cardioverter defibrillator lead placement in patient with hypertrophic obstructive cardiomyopathy
【2h】

Atrial fibrillation deteriorates tricuspid regurgitation following implantable cardioverter defibrillator lead placement in patient with hypertrophic obstructive cardiomyopathy

机译:肥厚性梗阻性心肌病患者植入可植入式心脏复律除颤器导线后房颤会恶化三尖瓣关闭不全

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although atrial fibrillation (AF) often exists in patients with hypertrophic obstructive cardiomyopathy (HOCM), combination of tricuspid regurgitation (TR) and AF after implantation of pacemaker/implantable cardioverter defibrillator (ICD) lead and its optimal management have not been well discussed in this population. Herein, we present a patient with HOCM who subsequently died due to severe heart failure and deterioration of TR following ICD lead placement with AF. Autopsy findings demonstrated that ICD leads were entrapped by anomaly structure in the right atrium and ventricle, which might affect deterioration of TR.
机译:尽管肥厚性梗阻性心肌病(HOCM)患者常存在房颤(AF),但在植入起搏器/植入式心脏复律除颤器(ICD)导线后三尖瓣关闭不全(TR)和AF的结合及其最佳治疗方法尚未得到很好的讨论。人口。本文中,我们介绍了一名HOCM患者,该患者随后因严重心力衰竭和ICD导线放置AF导致TR恶化而死亡。尸检结果表明,ICD导线被右心房和心室的异常结构所包裹,这可能会影响TR的恶化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号